One platform to build, fine-tune, and deploy. No MLOps team required.
Access Gemini 3 and 200+ models. Build chatbots, agents, or custom models with built-in monitoring and scaling.
Try Free
Our Free Plans just got better! | Auth0
With up to 25k MAUs and unlimited Okta connections, our Free Plan lets you focus on what you do best—building great apps.
You asked, we delivered! Auth0 is excited to expand our Free and Paid plans to include more options so you can focus on building, deploying, and scaling applications without having to worry about your security. Auth0 now, thank yourself later.
GPPCC is Graphical Pretty Print C++ Compiler. It supports C++99. This is a front end compiler tool for C++. This will convert unformatted C++ source file into formatted C++ source file with a prefix "pp_". For further information please read documentation.
XGP is an integrated development environment that extends GNU Prolog to work with Cocoa under Macintosh OS X. It provides user interface and graphics facilities largely compatible with MacProlog32 by LPA. Requires Mac OS X version 10.2.1 or greater.
ferite is a modern, lighweight, portable, threadsafe scripting engine with a language that is very easy to pick up and leverage for any task. It\'s been designed for rapid deployment in other programs as well as stand alone use.
A script(ing/ed/able) optimizing compiler for the C and Objective-C languages (and in the future other languages such as C++, D and Java). Written in a scripting language to allow for experimentation with code generation and optimization techniques.
AppSignal starts at $23/month with all features included. No overages, no hidden fees. 30-day free trial.
Tired of monitoring tools that punish you for scaling? AppSignal offers transparent, predictable pricing with every feature unlocked on every plan. Track errors, monitor performance, detect anomalies, and manage logs across Ruby, Python, Node.js, and more. Trusted by developers since 2012 with free dev-to-dev support. No credit card required to start your 30-day trial.